Addlestone, United Kingdom

Michael Neale

This inventor holds 1 USPTO granted patent. Top assignee: Animal, Plant and Fisheries Quarantine and Inspection Agency. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Neale. Retrieved from https://idiyas.com/inventor/michael-neale

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Neale: Innovator in Transmissible Spongiform Encephalopathy Research

Introduction

Michael Neale is a notable inventor based in Addlestone, GB. He has made significant contributions to the field of transmissible spongiform encephalopathy (TSE) research. His work focuses on the preparation of cells that are susceptible to TSE, which has important implications for diagnosis and therapeutic development.

Latest Patents

Michael Neale holds a patent for a method of preparing cells susceptible to transmissible spongiform encephalopathy. This patent, titled "Method of preparing cells susceptible to transmissible spongiform encephalopathy and the creation of TSE persistently infected cells," outlines a method for the efficient preparation of TSE-susceptible cells. These cells can be utilized in various applications, including the diagnosis of TSE, etiology studies, and the development of novel therapeutics. He has 1 patent to his name.

Career Highlights

Michael Neale is associated with the Animal, Plant and Fisheries Quarantine and Inspection Agency. His role in this organization allows him to contribute to important research and development efforts in the field of infectious diseases.

Collaborations

Michael has collaborated with notable colleagues, including Dong-Seob Tark and Hyo-Jin Kim. Their combined expertise enhances the research efforts in TSE and related fields.

Conclusion

Michael Neale's innovative work in the preparation of TSE-susceptible cells represents a significant advancement in the understanding and treatment of transmissible spongiform encephalopathy. His contributions are vital for future research and therapeutic developments in this critical area of study.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…